Doxaminer LAB A/S

CVR 45372812 · Public limited company (A/S) · Active · Medium risk

Doxaminer LAB A/S is a Public limited company (A/S), founded on , based in Vejle Øst. The company is registered in the industry computerprogrammering. Our model estimates a bankruptcy risk of 1.8% over the next 12 months, which is 1.3 times the average for Danish companies. 1 annual report has been published. The latest annual report (30 Jun 2026) shows equity of DKK 372k and a net result of DKK -28k. CEO: Michael Slipsager.

Bankruptcy risk for Doxaminer LAB A/S

1.8%
probability of bankruptcy within 12 months
Medium risk

1.3 × the average (1.41%) · higher risk than 81% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)1 yrs · bankruptcy rate 21.6%2.5×
Published annual reports1 · bankruptcy rate 18.7%2.1×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Company typeA/S · bankruptcy rate 4.4%0.50×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Auditor's statementAudit · bankruptcy rate 5.8%0.66×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
45372812
Status
Active
Company type
Public limited company (A/S)
Founded
(1 years)
Address
Tirsbækvej 191
7120 Vejle Øst
Municipality
Vejle
Industry
Computerprogrammering (621000)
Bankruptcies in the industry: Konsulentbistand vedrørende informationsteknologi
Share capital
DKK 400k
Auditor
EY Godkendt Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 1
Missing annual reportNo
Negative equityNo
Equity ratio93.0%
Current ratio37%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address13
Going-concern uncertaintyNo

Financials and key figures

Financial year2026
Gross profitDKK -21k
Net profitDKK -28k
EquityDKK 372k
Total assetsDKK 400k
CashDKK 6,526
Short-term debtDKK 28k
Avg. employees0

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · EY Godkendt Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
2 Feb 2025 – 30 Jun 202685

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOMichael SlipsagerCurrent
BoardLars TorpCurrent
BoardLars Tylvad AndersenCurrent
BoardMichael SlipsagerCurrent
BoardJan Leon Lovmand
Owner (100%)KILO VC4 ApSCurrent
AuditorEY Godkendt RevisionspartnerselskabCurrent
FounderKILO VC4 ApSCurrent

The CEOs' other companies

Michael Slipsager – 24 other companies, of which 1 bankrupt

Address history (0 moves)

Tirsbækvej 191, 7120 Vejle Øst

Other companies at the same address

Similar companies in Vejle

Questions and answers about Doxaminer LAB A/S

Has Doxaminer LAB A/S gone bankrupt?

No, Doxaminer LAB A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Doxaminer LAB A/S?

Our model estimates a bankruptcy risk of 1.8% over the next 12 months (medium risk), which is 1.3 times the average for Danish companies.

Who is the CEO of Doxaminer LAB A/S?

Michael Slipsager is the CEO of Doxaminer LAB A/S.

Who is the auditor of Doxaminer LAB A/S?

Doxaminer LAB A/S most recently used EY Godkendt Revisionspartnerselskab.

When was Doxaminer LAB A/S founded?

Doxaminer LAB A/S was founded on 2 February 2025.

What is the equity of Doxaminer LAB A/S?

Equity was DKK 372k according to the annual report for the period ending 30 June 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.